Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nicholas C P Cross

Showing results (61-70 of 221) with videos related to

Pageof 23
Sort By:
The Journal of Molecular Diagnostics : JMD|March 27, 2007
Amplification refractory mutation system, a highly sensitive and simple polymerase chain reaction assay, for the detection of JAK2 V617F mutation in chronic myeloproliferative disordersQiaofang Chen, Pin Lu, Amy V Jones, et al.
Genetic Testing|October 18, 2005
Accurate detection and quantitation of heteroplasmic mitochondrial point mutations by pyrosequencingHelen E White, Victoria J Durston, Anneke Seller, et al.
Haematologica|December 7, 2005
Chronic neutrophilic leukemia with an associated V617F JAK2 tyrosine kinase mutationDonald P Mc Lornan, Melanie J Percy, Amy V Jones, et al.
Acta Haematologica|November 24, 2017
A Novel PCM1-PDGFRB Fusion in a Patient with a Chronic Myeloproliferative Neoplasm and an ins(8;5)Muna Ghazzawi, Varun Mehra, Marcin Knut, et al.
Haematologica|March 18, 2017
Ruxolitinib, a potent JAK1/JAK2 inhibitor, induces temporary reductions in the allelic burden of concurrent <i>CSF3R</i> mutations in chronic neutrophilic leukemiaArief S Gunawan, Donal P McLornan, Bridget Wilkins, et al.
Haematologica|May 16, 2002
A further case of acute myeloid leukaemia with inv(8)(p11q13) and MOZ-TIF2 fusionAtto Billio, E Joanna Steer, Graziano Pianezze, et al.
Acta Haematologica|May 8, 2019
A Novel t(1;9)(p36;p24.1) JAK2 Translocation and Review of the LiteratureHannah Levavi, Joseph Tripodi, Bridget Marcellino, et al.
Leukemia & Lymphoma|November 29, 2012
Recurrent CEP85L-PDGFRB fusion in patient with t(5;6) and imatinib-responsive myeloproliferative neoplasm with eosinophiliaNils Winkelmann, Claire Hidalgo-Curtis, Katherine Waghorn, et al.
Haematologica|January 13, 2010
A polymorphism associated with STAT3 expression and response of chronic myeloid leukemia to interferon αSebastian Kreil, Katherine Waghorn, Thomas Ernst, et al.
Blood|April 26, 2007
Heterogeneous prognostic impact of derivative chromosome 9 deletions in chronic myelogenous leukemiaSebastian Kreil, Markus Pfirrmann, Claudia Haferlach, et al.
Pageof 23

Showing results (61-70 of 221) with videos related to

Sort By:
Pageof 23
The Journal of Molecular Diagnostics : JMD|March 27, 2007
Amplification refractory mutation system, a highly sensitive and simple polymerase chain reaction assay, for the detection of JAK2 V617F mutation in chronic myeloproliferative disordersQiaofang Chen, Pin Lu, Amy V Jones, et al.
Genetic Testing|October 18, 2005
Accurate detection and quantitation of heteroplasmic mitochondrial point mutations by pyrosequencingHelen E White, Victoria J Durston, Anneke Seller, et al.
Haematologica|December 7, 2005
Chronic neutrophilic leukemia with an associated V617F JAK2 tyrosine kinase mutationDonald P Mc Lornan, Melanie J Percy, Amy V Jones, et al.
Acta Haematologica|November 24, 2017
A Novel PCM1-PDGFRB Fusion in a Patient with a Chronic Myeloproliferative Neoplasm and an ins(8;5)Muna Ghazzawi, Varun Mehra, Marcin Knut, et al.
Haematologica|March 18, 2017
Ruxolitinib, a potent JAK1/JAK2 inhibitor, induces temporary reductions in the allelic burden of concurrent <i>CSF3R</i> mutations in chronic neutrophilic leukemiaArief S Gunawan, Donal P McLornan, Bridget Wilkins, et al.
Haematologica|May 16, 2002
A further case of acute myeloid leukaemia with inv(8)(p11q13) and MOZ-TIF2 fusionAtto Billio, E Joanna Steer, Graziano Pianezze, et al.
Acta Haematologica|May 8, 2019
A Novel t(1;9)(p36;p24.1) JAK2 Translocation and Review of the LiteratureHannah Levavi, Joseph Tripodi, Bridget Marcellino, et al.
Leukemia & Lymphoma|November 29, 2012
Recurrent CEP85L-PDGFRB fusion in patient with t(5;6) and imatinib-responsive myeloproliferative neoplasm with eosinophiliaNils Winkelmann, Claire Hidalgo-Curtis, Katherine Waghorn, et al.
Haematologica|January 13, 2010
A polymorphism associated with STAT3 expression and response of chronic myeloid leukemia to interferon αSebastian Kreil, Katherine Waghorn, Thomas Ernst, et al.
Blood|April 26, 2007
Heterogeneous prognostic impact of derivative chromosome 9 deletions in chronic myelogenous leukemiaSebastian Kreil, Markus Pfirrmann, Claudia Haferlach, et al.
Pageof 23